Elevated serum levels of IGFBP-2 found in children suffering from acute leukaemia is accompanied by the occurrence of IGFBPm2 mRNA in the tumour clone
1998

Elevated IGFBP-2 Levels in Children with Acute Leukaemia

Sample size: 50 publication Evidence: moderate

Author Information

Author(s): H Wexl, P Vorwerk, K Mohnike, D Bretschneider, U Kluba, V Aumann, WF Blum, U Mittler

Primary Institution: Otto-von-Guericke University Magdeburg

Hypothesis

Does elevated serum IGFBP-2 in children with acute leukaemia indicate tumor expression and potential relapse risk?

Conclusion

The study concluded that elevated serum IGFBP-2 levels in children with acute leukaemia are primarily due to tumor expression.

Supporting Evidence

  • IGFBP-2 serum levels were significantly elevated in ALL patients compared to control groups.
  • 72% of ALL patients had detectable IGFBP-2 mRNA at diagnosis.
  • IGFBP-2 levels normalized during chemotherapy.

Takeaway

Kids with a type of blood cancer have higher levels of a protein called IGFBP-2, which comes from their tumors and can help doctors understand their condition better.

Methodology

Serum levels of IGFBP-1, -2, and -3 were measured in children with acute lymphoblastic leukaemia and compared to control groups, along with gene expression analysis using RT-PCR.

Limitations

The study may not account for other sources of IGFBP-2 in serum, such as liver production.

Participant Demographics

Children aged 1.1 to 16.3 years with acute lymphoblastic leukaemia.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication